This modification is critical for stem cell maintenance and DNA repair.[81] In the context of cancer, PRMT1 silencing inhibits multiple myeloma cell proliferation and tumorigenesis by reducing oxidative phosphorylation via NDUFS6 downregulation. This evidence concerns the gene PRMT1 and plasma cell myeloma.